CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...